Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin / kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study - Giugliano, R P; Desai, N R; Kohli, P (Lancet, 2012)
et al.